STOCK TITAN

Indivior to Participate in the Stifel 2025 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Indivior (NASDAQ: INDV) will participate in the Stifel 2025 Healthcare Conference in New York City.

Chief Executive Officer Joe Ciaffoni and Chief Financial Officer Ryan Preblick will host 1x1 and group meetings and will appear in a public fireside discussion on Thursday, November 13, 2025 at 8:40 a.m. U.S. EST. Interested investors should contact their Stifel representative to schedule meetings. The fireside discussion will be available via a public webcast.

Indivior (NASDAQ: INDV) parteciperà alla Stifel 2025 Healthcare Conference a New York.

Il Amministratore Delegato Joe Ciaffoni e il Direttore Finanziario Ryan Preblick condurranno incontri one-to-one e di gruppo e parteciperanno a un dibattito pubblico informale giovedì 13 novembre 2025 alle 8:40 (ora EST degli Stati Uniti). Gli investitori interessati dovrebbero contattare il loro rappresentante Stifel per fissare gli incontri. Il dibattito pubblico sarà disponibile tramite webcast pubblico.

Indivior (NASDAQ: INDV) participará en la Stifel 2025 Healthcare Conference en la ciudad de Nueva York.

El Director Ejecutivo Joe Ciaffoni y el Director Financiero Ryan Preblick organizarán reuniones 1x1 y en grupo y participarán en una charla informal junto a la chimenea el jueves, 13 de noviembre de 2025 a las 8:40 a. m. EST. Los inversores interesados deben ponerse en contacto con su representante de Stifel para programar reuniones. La charla será transmitida en un webcast público.

Indivior (NASDAQ: INDV)는 뉴욕시에서 열리는 Stifel 2025 Healthcare Conference에 참여할 예정입니다.

CEO Joe Ciaffoni와 CFO Ryan Preblick은 1:1 및 그룹 미팅을 주최하고 공개 파이어사이드 토론2025년 11월 13일 목요일 오전 8:40(미국 동부 표준시)에 참석합니다. 회의 일정을 잡으려면 투자자분들이 Stifel 담당자에게 연락해야 합니다. 파이어사이드 토론은 공개 웹캐스트로 시청할 수 있습니다.

Indivior (NASDAQ: INDV) participera à la Stifel 2025 Healthcare Conference à New York.

Le CEO Joe Ciaffoni et le Directeur financier Ryan Preblick animeront des réunions en tête-à-tête et en groupe et participeront à une discussion informelle au coin du feu le jeudi 13 novembre 2025 à 8h40, heure standard de l’Est (EST). Les investisseurs intéressés doivent contacter leur représentant Stifel pour organiser les rencontres. La discussion autour du feu sera accessible via une diffusion webcast publique.

Indivior (NASDAQ: INDV) wird an der Stifel 2025 Healthcare Conference in New York teilnehmen.

Der CEO Joe Ciaffoni und der CFO Ryan Preblick werden 1-zu-1- und Gruppenmeetings abhalten und an einer öffentlichen Fireside-Diskussion am Donnerstag, dem 13. November 2025 um 8:40 Uhr EST teilnehmen. Interessierte Investoren sollten sich an ihren Stifel-Vertreter wenden, um Meetings zu vereinbaren. Die Fireside-Diskussion wird per öffentlich zugänglichem Webcast verfügbar sein.

Indivior (NASDAQ: INDV) ستشارك في مؤتمر ستيفل للرعاية الصحية 2025 في مدينة نيويورك.

سيعقد الرئيس التنفيذي جو شيّايفوني والمدير المالي ريان بريبلِك اجتماعات ثنائية وشخصية، وسيشاركان في نقاش علني بجلسة أمام الموقد الخميس 13 نوفمبر 2025 في الساعة 8:40 صباحاً بتوقيت شرق الولايات المتحدة. يجب على المستثمرين المهتمين التواصل مع ممثل ستيفل لديهم لترتيب الاجتماعات. سيتم بث النقاش أمام الموقد عبر بث حي عام.

Indivior (NASDAQ: INDV) 将参加位于纽约市的 Stifel 2025 Healthcare Conference

首席执行官 Joe Ciaffoni 与首席财务官 Ryan Preblick 将主持一对一及小组会谈,并于 2025 年 11 月 13 日(星期四)美东时间上午 8:40 出席公开炉边讨论。感兴趣的投资者应联系他们的 Stifel 代表以安排会谈。炉边讨论将通过公开网络广播进行。

Positive
  • None.
Negative
  • None.

RICHMOND, Va., Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference:

  • Stifel 2025 Healthcare Conference – New York City, NY

    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Thursday, November 13th. Joe Ciaffoni and Ryan Preblick will also participate in a fireside discussion on Thursday, November 13th at 8:40 a.m. U.S. EST. Interested investors should contact their Stifel representative to schedule a meeting.

    The fireside discussion will be publicly available and can be viewed using the following weblink: Stifel Fireside Chat Live Webcast.

About Indivior
Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-the-stifel-2025-healthcare-conference-302596900.html

SOURCE Indivior PLC

FAQ

When will Indivior (INDV) present at the Stifel 2025 Healthcare Conference?

Indivior will present on Thursday, November 13, 2025, with the fireside discussion at 8:40 a.m. U.S. EST.

Who from Indivior (INDV) will attend the Stifel 2025 Healthcare Conference?

CEO Joe Ciaffoni and CFO Ryan Preblick will host meetings and participate in the fireside discussion.

How can investors schedule meetings with Indivior (INDV) at the Stifel conference?

Investors should contact their Stifel representative to request 1x1 or group meeting slots on November 13.

Will the Indivior (INDV) fireside discussion at Stifel be available to the public?

Yes. The fireside discussion will be publicly available via webcast.

What time is the Indivior (INDV) fireside chat at the Stifel 2025 Healthcare Conference?

The fireside chat is scheduled for 8:40 a.m. U.S. EST on November 13, 2025.

Where is the Stifel 2025 Healthcare Conference taking place for Indivior (INDV)?

The conference is in New York City, NY; Indivior's meetings and fireside discussion are scheduled for November 13, 2025.
Indivior

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

3.14B
119.94M
3.88%
88.1%
6.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE